EVLV - Evolv Technology crumbles 40% after earnings guidance shows up to $85M loss: Q4 Report

Evolv Technology (NASDAQ:EVLV) fell 40% in early Tuesday trading after the company projected heavy loss under FY22 guidance given in its 4Q21 earnings report. 4Q21 revenue was $6.8M (+236% Y/Y). That takes Evolv's FY21 revenue to $23.7M (+395% Y/Y). Total contract value for the quarter stood at $17.9M (+201% Y/Y). Annual recurring revenue was $12.9M. Net Income was $2.5M or GAAP EPS of $0.02 (vs. -$1.06 in 4Q20) The company ended the fiscal year with $307.5M in cash and cash and cash equivalents following its SPAC listing with NewHold Investment in Jul 2021. Issues FY22 Guidance: The company expects its annual revenue to range between $29-$31M; annual recurring revenue of $27-$28M; Operating Loss of ($82-$84M); Adjusted EBITDA loss of ($65-$67M); and Net Income Loss of ($83-$85M).

For further details see:

Evolv Technology crumbles 40% after earnings guidance shows up to $85M loss: Q4 Report